TY - JOUR
T1 - Head and neck cancer survival disparities by race and rural–urban context
AU - Clarke, Jacob A.
AU - Despotis, Alyssa M.
AU - Ramirez, Ricardo J.
AU - Zevallos, Jose P.
AU - Mazul, Angela L.
N1 - Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Background: This study aims to examine the relationship between race and rural–urban context in head and neck cancer (HNC) survival and determine factors that potentially drive this disparity. Methods: Using the National Cancer Database from 2004 to 2015, we identified a retrospective cohort of 146,256 patients with HNC. Kaplan–Meier survival curves and the Cox proportional hazards regression were used to calculate adjusted HRs. Results: Median survival by patient subgroup was as follows: White urban [67 months; 95% confidence interval (CI), 66.0–67.9], White rural (59.1 months; 95% CI, 57.2–60), Black urban (43.1 months; 95% CI, 41.1–44.5), and Black rural (35.1 months; 95% CI, 31.9–39.0). The difference in 5-year survival, stratified by rural–urban context, was greater among Black patients [D restricted mean survival time (DRMST) 0.18; 95% CI, 0.10–0.27] than White patients (DRMST 0.08; 95% CI, 0.06–0.11). In the univariate Cox proportional hazards analysis with White urban patients as reference group, Black rural patients had the worst survival (HR, 1.45; 95% CI, 1.43–1.48; P < 0.001), followed by Black urban patients (HR, 1.29; 95% CI, 1.28–1.30; P < 0.001), and White rural patients (HR, 1.08; 95% CI, 1.07–1.09; P < 0.001). This disparity persisted when controlling for demographic, socioeconomic, and clinical factors. Conclusions: Black patients with HNC, specifically those living in rural areas, have decreased survival. Survival differences by rural–urban status are greater among Black patients than White patients. Impact: We have shown that race and rural–urban status impact HNC survival outcomes. Our findings will help future researchers to better frame approaches to address this disparity.
AB - Background: This study aims to examine the relationship between race and rural–urban context in head and neck cancer (HNC) survival and determine factors that potentially drive this disparity. Methods: Using the National Cancer Database from 2004 to 2015, we identified a retrospective cohort of 146,256 patients with HNC. Kaplan–Meier survival curves and the Cox proportional hazards regression were used to calculate adjusted HRs. Results: Median survival by patient subgroup was as follows: White urban [67 months; 95% confidence interval (CI), 66.0–67.9], White rural (59.1 months; 95% CI, 57.2–60), Black urban (43.1 months; 95% CI, 41.1–44.5), and Black rural (35.1 months; 95% CI, 31.9–39.0). The difference in 5-year survival, stratified by rural–urban context, was greater among Black patients [D restricted mean survival time (DRMST) 0.18; 95% CI, 0.10–0.27] than White patients (DRMST 0.08; 95% CI, 0.06–0.11). In the univariate Cox proportional hazards analysis with White urban patients as reference group, Black rural patients had the worst survival (HR, 1.45; 95% CI, 1.43–1.48; P < 0.001), followed by Black urban patients (HR, 1.29; 95% CI, 1.28–1.30; P < 0.001), and White rural patients (HR, 1.08; 95% CI, 1.07–1.09; P < 0.001). This disparity persisted when controlling for demographic, socioeconomic, and clinical factors. Conclusions: Black patients with HNC, specifically those living in rural areas, have decreased survival. Survival differences by rural–urban status are greater among Black patients than White patients. Impact: We have shown that race and rural–urban status impact HNC survival outcomes. Our findings will help future researchers to better frame approaches to address this disparity.
UR - http://www.scopus.com/inward/record.url?scp=85100268966&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-20-0376
DO - 10.1158/1055-9965.EPI-20-0376
M3 - Article
C2 - 32727721
AN - SCOPUS:85100268966
SN - 1055-9965
VL - 29
SP - 1955
EP - 1961
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 10
ER -